Article Text

other Versions

PDF
Randomised controlled trial
High-dose barium impaction therapy is a practical option for reducing recurrence of colonic diverticular bleeding
  1. Mikihiro Fujiya
  1. Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan
  1. Correspondence to: Dr Mikihiro Fujiya, Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, 2-1-1-1, Midorigaoka-higashi, Asahikawa, Hokkaido 078-8510, Japan; fjym{at}asahikawa-med.ac.jp

Statistics from Altmetric.com

Commentary on:

Context

Colonic diverticular bleeding (CDB) accounts for approximately 40% of all cases of acute lower gastrointestinal bleeding. Most cases of CDB resolve without surgery, although the rebleeding rate is high even when therapeutic procedures, including endoscopy and angiography, are successful. This leads to frequent examinations, hospitalisation and blood transfusion and a decrease in the quality of life. It has been reported that transanal administration of a high-dose barium enema provides better clinical outcomes for initial haemostasis and the long-term prevention of rebleeding than conservative therapy. However, no controlled study concerning this procedure has been conducted. The present randomised controlled trial investigated the efficacy of barium impaction …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.